BRUSSELS (Reuters) - European Union health ministers failed on Wednesday to agree a common guidance on the use of the AstraZeneca COVID-19 vaccine, despite calls for coordination across member states to combat public hesitancy over taking the shot.
Ministers held an extraordinary virtual meeting just after the European Medicines Agency (EMA) changed its guidance on the vaccine as it found possible links with very rare cases of unusual blood clots with low blood platelet counts, although it said the vaccine's advantages still outweighed risks.